메뉴 건너뛰기




Volumn 41, Issue 9, 2009, Pages 3639-3641

Sirolimus Therapy for Patients With Adult Polycystic Kidney Disease: A Pilot Study

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CREATININE; RAPAMYCIN; TELMISARTAN; THIAZIDE DIURETIC AGENT;

EID: 71749087934     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.05.032     Document Type: Article
Times cited : (14)

References (9)
  • 1
    • 0020569860 scopus 로고
    • Rate of functional deterioration in polycystic kidney disease
    • Franz K.A., and Reubi F.C. Rate of functional deterioration in polycystic kidney disease. Kidney Int 23 (1983) 526
    • (1983) Kidney Int , vol.23 , pp. 526
    • Franz, K.A.1    Reubi, F.C.2
  • 2
    • 33646710257 scopus 로고    scopus 로고
    • Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes
    • Grantham J.J., Chapman A.B., and Torres V.E. Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes. Clin J Am Soc Nephrol 1 (2006) 148
    • (2006) Clin J Am Soc Nephrol , vol.1 , pp. 148
    • Grantham, J.J.1    Chapman, A.B.2    Torres, V.E.3
  • 3
    • 0035058557 scopus 로고    scopus 로고
    • Progression of autosomal-dominant polycystic kidney disease in children
    • Fick-Brosnahan G.M., Tran Z.V., Johnson A.M., et al. Progression of autosomal-dominant polycystic kidney disease in children. Kidney Int 59 (2001) 1654
    • (2001) Kidney Int , vol.59 , pp. 1654
    • Fick-Brosnahan, G.M.1    Tran, Z.V.2    Johnson, A.M.3
  • 4
    • 33646678189 scopus 로고    scopus 로고
    • Volume progression in polycystic kidney disease
    • Grantham J.J., Torres V.E., Chapman A.B., et al. Volume progression in polycystic kidney disease. N Engl J Med 354 (2006) 2122
    • (2006) N Engl J Med , vol.354 , pp. 2122
    • Grantham, J.J.1    Torres, V.E.2    Chapman, A.B.3
  • 5
    • 0034468489 scopus 로고    scopus 로고
    • Volumetric measurement of renal cysts and parenchyma using MRI: phantoms and patients with polycystic kidney disease
    • Bae K.T., Commean K.P.K., and Lee J. Volumetric measurement of renal cysts and parenchyma using MRI: phantoms and patients with polycystic kidney disease. J Comput Assist Tomogr 24 (2000) 614
    • (2000) J Comput Assist Tomogr , vol.24 , pp. 614
    • Bae, K.T.1    Commean, K.P.K.2    Lee, J.3
  • 6
    • 12444274302 scopus 로고    scopus 로고
    • Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD). The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) Cohort
    • Chapman A.B., Guay-Woodford L.M., Grantham J.J., et al. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD). The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) Cohort. Kidney Int 64 (2003) 1035
    • (2003) Kidney Int , vol.64 , pp. 1035
    • Chapman, A.B.1    Guay-Woodford, L.M.2    Grantham, J.J.3
  • 7
    • 33645769011 scopus 로고    scopus 로고
    • The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease
    • Shillingford J.M., Murcia N.S., Larson C.H., et al. The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease. Proc Natl Acad Sci USA 103 (2006) 5466
    • (2006) Proc Natl Acad Sci USA , vol.103 , pp. 5466
    • Shillingford, J.M.1    Murcia, N.S.2    Larson, C.H.3
  • 8
    • 18744380752 scopus 로고    scopus 로고
    • Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease
    • Tao Y., Kim J., Schreier K.W., et al. Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease. J Am Soc Nephrol 16 (2005) 46
    • (2005) J Am Soc Nephrol , vol.16 , pp. 46
    • Tao, Y.1    Kim, J.2    Schreier, K.W.3
  • 9
    • 33644859253 scopus 로고    scopus 로고
    • Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal-dominant polycystic kidney disease (ADPKD)
    • Wahl P.R., Serra A.L., Leltir M., et al. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal-dominant polycystic kidney disease (ADPKD). Nephrol Dial Transplant 21 (2006) 598
    • (2006) Nephrol Dial Transplant , vol.21 , pp. 598
    • Wahl, P.R.1    Serra, A.L.2    Leltir, M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.